Top branded biologic drugs in the U.S. that will go generic by 2028

This statistic shows a list of selected top branded biologic drugs in the United States that will go generic by 2028 as a result of expired patents, listed by revenue. One of these top branded drugs is Humira, which generates around 8.5 billion U.S. dollars worth of revenue in the U.S. pharmaceutical market annually and will go generic in 2016.

Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*

Drug name and date of patent expiryRevenue in billion U.S. dollars
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2016

Region

United States

Survey time period

2016

Supplementary notes

* For all of these drugs, the existing patent will expire by 2028, which allows generic versions to then be made thereafter. The statistic is based on U.S. revenue only.
Revenue figures are the moving annual total (MAT) for June 2015.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Generics and biosimilars"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.